Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.50 |
| ▸ | STAT6 | P42226 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.50 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.50 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.50 |
| ▸ | GAPDH | P04406 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL830796 | 1.00 | MAPK1 (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL453482 | 0.87 | MAPK1 (0.46) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL453483 | 0.87 | MAPK1 (0.46) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL15973691 | 0.86 | ADK (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL1666083 | 0.86 | HSPA5 (0.52) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL3841527 | 0.86 | DOT1L (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL1936249 | 0.86 | ADK (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL1936244 | 0.86 | ADK (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL724943 | 0.86 | MAPK1 (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 | |
| SCHEMBL27767961 | 0.86 | DOT1L (0.50) | MAPK1DOT1LSTAT6HIF1ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250223593-A1 | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES | PROQR THERAPEUTICS II B.V. (NL) | 2025-07-10 | — | — | US | claimed |
| CN-118613500-A | Modified mRNA treatment | 沙塔克实验室有限公司 | 2024-09-06 | — | — | CN | claimed |
| EP-4379052-A2 | MRNA PURIFICATION BY TANGENTIAL FLOW FILTRATION | Ethris GmbH (DE) | 2024-06-05 | — | — | EP | claimed |
| EP-4306643-A2 | PLASMID CONTAINING A SEQUENCE ENCODING AN MRNA WITH A SEGMENTED POLY(A) TAIL | ethris GmbH (DE) | 2024-01-17 | — | — | EP | claimed |
| US-11851656-B2 | Chemically modified single-stranded RNA-editing oligonucleotides | PROQR THERAPEUTICS II B.V. (NL) | 2023-12-26 | — | — | US | claimed |
| CN-110352244-B | Chemically modified RNA editing single stranded oligonucleotides | ProQR治疗上市公司Ⅱ | 2023-03-21 | — | — | CN | claimed |
| WO-2022000884-A1 | MANNOSE-BASED MRNA TARGETED DELIVERY SYSTEM AND USE THEREOF | 深圳市瑞吉生物科技有限公司 | 2022-01-06 | — | — | WO | claimed |
| US-20210238597-A1 | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES | PROQR THERAPEUTICS II B.V. (NL) | 2021-08-05 | — | — | US | claimed |
| US-10941402-B2 | Chemically modified single-stranded RNA-editing oligonucleotides | PROQR THERAPEUTICS II B.V. (NL) | 2021-03-09 | — | — | US | claimed |
| CN-112390871-A | In vivo production of proteins | 现代泰克斯公司 | 2021-02-23 | — | — | CN | claimed |
| EP-3507366-B1 | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES | PROQR THERAPEUTICS II BV (NL) | 2020-10-07 | — | — | EP | claimed |
| CN-110352244-A | The single-stranded oligonucleotide of the editor RNA of chemical modification | ProQR治疗上市公司Ⅱ | 2019-10-18 | — | — | CN | claimed |
| US-20190218552-A1 | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES | PROQR THERAPEUTICS II B.V. (NL) | 2019-07-18 | — | — | US | claimed |
| EP-3507366-A1 | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES | ProQR Therapeutics II B.V. (NL) | 2019-07-10 | — | — | EP | claimed |
| WO-2018041973-A1 | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES | PROQR THERAPEUTICS II B.V. (NL) | 2018-03-08 | — | — | WO | claimed |
| EP-4746905-A1 | RSV VACCINE | Astrazeneca AB (SE) | 2026-05-27 | — | — | EP | disclosed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| EP-0691980-B1 | 7-DEAZAPURINE MODIFIED OLIGONUCLEOTIDES | SANOFI SA (FR) | 1997-06-04 | — | — | EP | disclosed |
| EP-0691980-A1 | 7-DEAZAPURINE MODIFIED OLIGONUCLEOTIDES | STERLING WINTHROP INC (US) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022892-A1 | 7-DEAZAPURINE MODIFIED OLIGONUCLEOTIDES | STERLING WINTHROP INC. (US) | 1994-10-13 | — | — | WO | disclosed |